BioLineRx (BLRX) to Commence BL-8020 Phase I/II in Europe During Q113

Go back to BioLineRx (BLRX) to Commence BL-8020 Phase I/II in Europe During Q113
BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.85 --0 (-0%)
Previous Close $2.85    52 Week High $1.63 
Open $2.85    52 Week Low $0.71 
Day High $2.85    P/E N/A 
Day Low $2.85    EPS $0.00 
Volume 110